News
-
A consortium formed by Irish biotech OmniSpirant, nebulizer maker Aerogen, and the National University of Ireland Galway has received a €11.6 million grant from Ireland’s Disruptive Technologies Innovation Fund for development of OS002, an inhaled… Read more . . .
-
Teva Canada has launched the Aermony RespiClick fluticasone propionate DPI for the treatment of asthma, the company said. The inhaler will be available in 55 mcg, 113 mcg, and 232 mcg per actuation versions. According… Read more . . .
-
Starpharma said that it has raised A$45 million and expects to raise another A$5 million from Australian and international investors, with proceeds to be used for development of its SPL7013 astodrimer sodium nasal spray for… Read more . . .
-
AZTherapies said that it has closed a $33.6 million Series C-1 financing that will fund regulatory and pre-commercial activities related to the company’s ALZT-OP1 inhaled cromolyn/oral ibuprofen for Alzheimer’s disease and for development of other… Read more . . .
-
Researchers from the University of Texas at Austin and Chungnam National University have published in vitro and in vivo data demonstrating that a dry powder formulation of niclosamide that includes human lysozyme (hLYS) as a… Read more . . .
-
Ena Respiratory (formerly Innavac) said that its INNA-051 pegylated TLR2/6 agonist nasal spray reduced replication of the SARS-CoV-2 virus in a ferret model by up to 96% in a study conducted by researchers at Public… Read more . . .
-
Inhalation CDMO Vectura has announced the resignation of Aerami CEO Anne Whitaker from Vectura’s board of directors “in light of potential conflicts that could arise in the future as a result of her role of… Read more . . .
-
Nasal spray CDMO Summit Biosciences has nearly completed a $19 million expansion of its facility at the University of Kentucky Coldstream Research Campus that is expected to create 78 jobs, the state of Kentucky has… Read more . . .
-
Galecto said that it has completed a $64 million equity financing led by Soleus Capital that will be used to advance several candidates, including GB0139, a galectin-3 inhibitor DPI for the treatment of idiopathic pulmonary… Read more . . .
-
TFF Pharmaceuticals is drawing attention to in vitro data published by researchers at the University of Texas Austin which found that thin film freezing “produces high potency remdesivir dry powder formulations for inhalation suitable to… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.